08:00 AM EDT, 06/13/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) on Friday said it is declaring a special dividend of contingent value rights (CVRs) to be issued to holders of its Class B subordinate voting shares.

Each CVR will allow the holder to receive a pro rata portion ranging from 10% to up to 50% of the net proceeds, if recovered, from its legal action against CIBC World Markets, RBC Dominion Securities, and others. Quantum Biopharma ( QNTM ) is seeking damages of more than US$700+ million related to alleged stock price manipulation and "spoofing."

The board will approve the exact pay-out percentage at a later date.

Quantum BioPharma ( QNTM ) was last seen down US$0.23, to US$18.77 in U.S. pre-market trading.